<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00848835</url>
  </required_header>
  <id_info>
    <org_study_id>LEAD LIFE</org_study_id>
    <nct_id>NCT00848835</nct_id>
  </id_info>
  <brief_title>Long Term Integrity Follow-up Evaluation</brief_title>
  <acronym>LEAD LIFE</acronym>
  <official_title>Long Term Integrity Follow-up Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guidant Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guidant Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To document the performance of the Guidant ENDOTAK EZ and the RELIANCE defibrillation leads
      over 5 years.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are few prospective long term follow-up studies on implanted cardiac device
      (pacemaker/implantable cardioverter defibrillator (ICD)) survivability. This study will
      evaluate the long term performance (5 years) of the transvenous defibrillation leads (ENDOTAK
      ENDURANCE EZ and teh ENDOTAK RELIANCE. Data will be collected at implant, 1 and 6 months, 1,3
      and 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2002</start_date>
  <completion_date type="Actual">January 2010</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">372</enrollment>
  <condition>Sudden Cardiac Death</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>all patients in the control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>defibrillation lead (ENDOTAK EZ and RELIANCE)</intervention_name>
    <description>defibrillation lead</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients who are indicated for a market released ICD
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients selected for Guidant ICD system implant, available for follow-up at the
             defined intervals

        Exclusion Criteria:

          -  Patients enrolled in other studies, not available for follow-up, &lt; 18 yrs, unable to
             sign consent, life expectancy &lt; 1 year due to a medical condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lawrence Sterns, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Victoria Cardiac Arrythmia trials</affiliation>
  </overall_official>
  <verification_date>August 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2009</study_first_submitted>
  <study_first_submitted_qc>February 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 20, 2009</study_first_posted>
  <last_update_submitted>August 30, 2010</last_update_submitted>
  <last_update_submitted_qc>August 30, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2010</last_update_posted>
  <responsible_party>
    <name_title>Anne Swearingen</name_title>
    <organization>Boston Scientific</organization>
  </responsible_party>
  <keyword>defibrillator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

